StonvexLoading…
StonvexStonvexStonvexCore line items from NTLA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $67.67M | $57.88M | $36.27M | $52.12M |
Operating Income | $-440.99M | $-534.26M | $-515.29M | $-458.16M |
Net Income | $-412.69M | $-519.02M | $-481.19M | $-474.19M |
EPS (Diluted) | $-3.81 | $-5.25 | $-5.42 | $-6.16 |
Total Assets | $842.13M | $1.19B | $1.30B | $1.52B |
Total Liabilities | $170.73M | $319.06M | $250.81M | $284.53M |
Cash & Equivalents | $155.46M | $189.18M | $226.75M | $523.51M |
Free Cash Flow OCF − CapEx | $-395.87M | $-354.66M | $-408.07M | $-346.85M |
Shares Outstanding | 116.32M | 102.03M | 93.00M | 87.10M |